Department Of Dermatology
Larisa Geskin, MD

Dr. Larisa Geskin is an Associate Professor of Dermatology at Columbia University Medical Center and Director of the Comprehensive Skin Cancer Center (CSCC) at the Division of Cutaneous Oncology in the Department of Dermatology.

She is a world-renowned specialist in the diagnosis and management of cutaneous lymphomas and other cancers of the skin. Her other areas of expertise include melanoma screening, prevention, medical and surgical therapy, and management of high risk for skin cancer populations. Dr. Geskin is using state-of-the-art methods in melanoma screening and surveillance including Mole Mapping (body mapping) and dermoscopy. She was involved in development of novel melanoma detection methods, including MelaFind among others. Dr. Geskin's team aims to provide multidisciplinary care to skin cancer patients, to conduct cutting edge clinical and basic science research, and to train medical students, residents and fellows in the area of cutaneous oncology.

Dr. Geskin completed her residency in Dermatology at University of Pittsburgh Medical Center (UPMC), and a two-year fellowship in cutaneous oncology at University of Pittsburgh Cancer Institute (UPCI) with Louis Falo, MD, PhD, Professor and Chairman, Department of Dermatology, UPMC, and with John Kirkwood, MD, Professor and Vice Chairman for Clinical Research, Director of the Melanoma Center at the UPCI.

She is a diplomat of the American Academy of Dermatology, member of the Society for Investigative Dermatology, the International Society for Cutaneous Lymphomas, and US Cutaneous Lymphomas Consortium. She authored over 30 peer-reviewed articles in the field of cutaneous oncology. Her research interest focuses on Cutaneous T-cell lymphoma (CTCL) and biomarkers discovery, genetic profiling and regulation, development of immunotherapy for melanoma and lymphoma.

Clinical Studies Managed By This Investigator:
Condition Study Title
Lymphoma [ CLOSED ] An observational study for patients diagnosed with mycosis fungoides cutaneous lymphoma and treated with Valchlor
Lymphoma [ CLOSED ] A study for patients with Cutaneous T Cell Lymphoma (CTCL) using study drug NM-IL-12
Lymphoma [ CLOSED ] A study for patients with Cutaneous T-Cell Lymphoma/Mycosis Fungoides using topical lotion Naloxone in the treatment of itching
Lymphoma [ CLOSED ] Phase 3 Trial to Determine the Efficacy of Topical Hypericin combined with Fluorescent Light Therapy on Cutaneous T-Cell Lymphoma
Lymphoma [ CLOSED ] Efficacy and Safety of Naloxone Lotion for Treatment of Itchiness in Patients with Mycosis Fungoides (MF) Form of Cutaneous T-cell Lymphoma
Lymphoma [ CLOSED ] Study of Drug E7777 in Cutaneous T-Cell Lymphoma - Cancer of T-lymphocytes (type of white blood cells) that Involves the Skin
Melanoma [ CLOSED ] Study of Nivolumab in Patients with Resected Stage IIB/IIC Melanoma